if the FDA is going to pull Synthroid from the market

July 2001

Media reports have patients wondering if the FDA is going to pull Synthroid from the market.

This all started because levothyroxine has been on the market so long...many years before the FDA required New Drug Applications (NDA).

But potency problems have plagued levothyroxine products for years. This has finally prompted the FDA to require ALL levothyroxine products to apply for their own NDA approval.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote